You are here

TX

Access DX Laboratory, LLC

Project ID: 
39449
Facility ID: 
8808
Facility Name: 
Access DX Laboratory, LLC
Facility State: 
TX
Analyte: 
pharmacogenetic drug sensitivity testing (CYP2C9 with VKORC1, CYP2C19, CYP2D6, CYP3A4, CYP3A5, MTHFR, Factor II (prothrombin), Factor V (Leiden))
Method: 
PCR and SNP genotyping
Specimen Type: 
saliva
Permit Category: 
Genetic Testing - Molecular
Status: 
Approved

Access DX Laboratory, LLC

Project ID: 
62459
Facility ID: 
8808
Facility Name: 
Access DX Laboratory, LLC
Facility State: 
TX
Analyte: 
pregabalin confirmation
Method: 
LC-MS/MS
Specimen Type: 
urine
Permit Category: 
Toxicology - Clinical Toxicology-Comprehensive
Status: 
Approved

Access DX Laboratory, LLC

Project ID: 
62460
Facility ID: 
8808
Facility Name: 
Access DX Laboratory, LLC
Facility State: 
TX
Analyte: 
zolpidem confirmation
Method: 
LC-MS/MS
Specimen Type: 
urine
Permit Category: 
Toxicology - Clinical Toxicology-Comprehensive
Status: 
Approved

Access DX Laboratory, LLC

Project ID: 
55074
Facility ID: 
8808
Facility Name: 
Access DX Laboratory, LLC
Facility State: 
TX
Analyte: 
pharmacogenetic drug sensitivity testing (new marker additions for DNA Drug Sensitivity & Oncology Drug Sensitivity)
Method: 
PCR/SNP genotyping/fragment analysis/Sanger Sequencing
Specimen Type: 
saliva; whole blood
Permit Category: 
Genetic Testing - Molecular
Status: 
Conditionally Approved

Antiphospholipid Standardization Laboratory

Project ID: 
13484
Facility ID: 
8450
Facility Name: 
Antiphospholipid Standardization Laboratory
Facility State: 
TX
Analyte: 
anticardiolipin antibodies
Method: 
ELISA
Specimen Type: 
serum
Permit Category: 
Diagnostic Immunology - Diagnostic Services Serology
Status: 
Approved

Asuragen Clinical Services

Project ID: 
42392
Facility ID: 
8708
Facility Name: 
Asuragen Clinical Services
Facility State: 
TX
Analyte: 
Fragile X (FMR1 gene)
Method: 
PCR & capillary electrophoresis
Specimen Type: 
whole blood; other: DNA; buccal swab
Permit Category: 
Genetic Testing - Molecular
Status: 
Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
23542
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
cytochrome P450 2C19 (*2-*4, *6-*10, *17 alleles)
Method: 
genotyping
Specimen Type: 
saliva; whole blood
Permit Category: 
Genetic Testing - Molecular
Status: 
Conditionally Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
74619
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
Comprehensive GeneAware v3 (421 genes) carrier screening
Method: 
next generation sequencing
Specimen Type: 
saliva; whole blood; extracted DNA; buccal swab
Permit Category: 
Genetic Testing - Molecular
Status: 
Conditionally Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
1359
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
factor V Leiden
Permit Category: 
Genetic Testing - Molecular
Status: 
Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
1562
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
creatine/guanidinoacetate
Method: 
electrospray tandem MS
Specimen Type: 
plasma
Permit Category: 
Genetic Testing - Biochemistry
Status: 
Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
39749
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
Tay-Sachs carrier screening (Hexosaminidase A and B)
Method: 
fluorimetric enzyme analysis
Specimen Type: 
other: white blood cells; serum
Permit Category: 
Genetic Testing - Biochemistry
Status: 
Conditionally Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
1583
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
Lowe syndrome
Permit Category: 
Genetic Testing - Molecular
Status: 
Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
40429
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
Duchenne Muscular Dystrophy (DMD) deletion and duplication analysis
Method: 
high resolution array CGH
Specimen Type: 
whole blood: EDTA
Permit Category: 
Genetic Testing - Molecular
Status: 
Conditionally Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
52614
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
whole exome sequencing (Trio, Critical, Prenatal and Total BluePrint Panel) (modification)
Method: 
next generation sequencing
Specimen Type: 
purified DNA; whole blood: EDTA; cultured cells: fibroblasts; buccal swab
Permit Category: 
Genetic Testing - Molecular
Status: 
Conditionally Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
1615
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
CFTR poly T
Permit Category: 
Genetic Testing - Molecular
Status: 
Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
1832
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
spinal muscular atrophy (SMN deletion, prenatal)
Permit Category: 
Genetic Testing - Molecular
Status: 
Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
70599
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
GeneAware v3 carrier screening
Method: 
capture-next generation sequencing
Specimen Type: 
whole blood; extracted DNA
Permit Category: 
Genetic Testing - Molecular
Status: 
Conditionally Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
1881
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
ARX gene
Method: 
PCR of 5 exons followed by bi-directional sequencing
Specimen Type: 
whole blood
Permit Category: 
Genetic Testing - Molecular
Status: 
Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
71699
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
GeneAware v3 (274 genes) carrier screening (modification)
Method: 
next generation sequencing
Specimen Type: 
saliva
Permit Category: 
Genetic Testing - Molecular
Status: 
Conditionally Approved

Baylor Miraca Genetics Laboratories, LLC

Project ID: 
1882
Facility ID: 
4584
Facility Name: 
Baylor Miraca Genetics Laboratories, LLC
Facility State: 
TX
Analyte: 
Fabry disease (GLA gene)
Method: 
PCR of 7 exons followed by bi-directional sequencing
Specimen Type: 
whole blood; chorionic villus sample (CVS); amplicons: DNA; amniotic fluid
Permit Category: 
Genetic Testing - Molecular
Status: 
Approved
Subscribe to TX